Vigilance impairment after a single dose of benzodiazepines

@article{Koena1995VigilanceIA,
  title={Vigilance impairment after a single dose of benzodiazepines},
  author={L. Ko{\vz}ena and Emil Frant{\'i}k and Milan Horv{\'a}th},
  journal={Psychopharmacology},
  year={1995},
  volume={119},
  pages={39-45}
}
While outpatients or other users of therapeutic drugs have to be informed about the risk of impaired functioning during driving or work, the prescribing physician needs to be familiar with the side effects of alternative drugs in order to select the most suitable treatment. With this aim, several types of benzodiazepine anxiolytics in low anxiolytic doses (diazepam 5 mg or 10 mg, nitrazepam 5 mg, oxazepam 10 mg, medazepam 10 mg, and alprazolam 0.2 or 0.5 mg - per 2m2 body surface) were tested… 

Biomarkers for the effects of benzodiazepines in healthy volunteers.

Subjective and objective measures of alertness were most sensitive to benzodiazepines, and the most consistent effects were observed on saccadic peak velocity (SPV) and visual analogue scores ( VAS) of Alertness, where 100% and 79% of all studies respectively showed statistically significant effects.

Neurobehavioural performance effects of daytime melatonin and temazepam administration

Melatonin administration induces a smaller deficit in performance on a range of neurobehavioural tasks than temazepam, suggesting that melatonin may be preferable to benzodiazepines in the management of circadian and sleep disorders.

RESIDUAL NEXT-DAY EFFECTS OF ALPRAZOLAM ON PSYCHOMOTOR PERFORMANCE AND SIMULATED DRIVING IN HEALTHY NORMAL VOLUNTEERS

The results suggest that alprazolam used before bed may pose an as yet unrecognized public safety risk in the form of next-day drugged-driving.

Anti-Intrusion Effect of Lorazepam: An Experimental Study

Support is provided for the enhanced perceptual priming hypothesis of PTSD by suggesting the possibility of lorazepam as a candidate anti-intrusion drug, as well as the cautious use of diazepam in the treatment of PTSD patients.

A new behavioral test for assessment of drug effects on attentional performance and its validity in cynomolgus monkeys.

It is suggested that the present behavioral test method could detect drug effects on attentional performance in monkeys and could be a useful tool for safety assessment in drug development.

CNS Drug Reviews

Alprazolam is a benzodiazepine derivative that is currently used in the treatment of generalized anxiety, panic attacks with or without agoraphobia, and depression. Alprazolam has a fast onset of

Cognitive-Behavioral and Pharmacological Treatments for Insomnia: A Combined Approach

A combined (non-pharmacological and pharmacological)approach could be considered in poor responders to manage drug dependence and to increase compliance to treatment and patients’ quality of life.

Oxazepam alters action monitoring

Although the intake of 30 mg oxazepam did not impair behavioral performance, measures of the electrophysiological recordings show that action monitoring processes were altered, and it is argued that this may be related to the anxiolytic properties of the drug and may constitute an important causal factor for behavioral impairments after the intake.

Behavioral and Neurophysiological Signatures of Benzodiazepine-Related Driving Impairments

Criteria that could potentially improve the identification of benzodiazepine intoxication by DREs are identified and the promise for future studies using this approach to improve upon current, real-world assessments of impaired driving is demonstrated.

Benzodiazepines and driving pharmacological and legal aspects

Both physicians and pharmacists should advise their patients of the impairing effects of benzodiazepines, particularly in relation to drowsiness and sedation, and the implication of these effects on driving skills.

References

SHOWING 1-10 OF 33 REFERENCES

Benzodiazepines and vigilance performance: a review

There is no evidence that benzodiazepines aggravate the vigilance decrement occurring under normal conditions, and it is unlikely that impairments in vigilance are simply a byproduct of global, sedative effects, but there is uncertainty regarding measures of general sedation.

Residual effects of hypnotic drugs: Evidence for individual differences on vigilance

Examination of individual differences in the response of subjects to the 4 hypnotic drug treatments, compared with their responses after dummy indicated that subjects could be divided into two groups, and it is suggested that the improvement in the first group resulted from improved sleep quality sufficient to counteract the residual effect of the hypnotic.

The effects of a single oral dose of lorazepam and alprazolam on reaction times in young healthy volunteers.

This finding is interpreted as a partial recuperative effect for the impaired performance in the baseline condition after intake of lorazepam.

Acute and carry-over effects of brotizolam compared to nitrazepam and placebo in monotonous simulated driving.

Reaction time decrement was observed in both active drugs conditions with no difference between the two, and other measures, however non-significant, pointed in the same direction with the greatest decrement for nitrazepam.

Effects of buspirone and alprazolam on the cognitive performance of normal elderly subjects.

Buspirone did not produce behavioral side effects that could lead to disability, and alprazolam had minimal side effects, and it is unclear whether these medications in the doses used would have more side effects in less healthy elderly patients.

Central effects of the calcium antagonist, nifedipine.

Central effects of the calcium antagonist, nifedipine retard (10, 20 and 40 mg) and nifingipine capsules (10 mg) were studied in 14 healthy male subjects and performance was assessed using digit symbol substitution, continuous attention, letter cancellation, choice reaction time, finger tapping, immediate and short-term memory.

Central effects of the angiotensin-converting enzyme inhibitor, captopril. I. Performance and subjective assessments of mood.

Although central effects may exist with captopril, no adverse consequences have been established on performance or on subjective assessment of mood, and Captopril may, therefore, be an appropriate drug for hypertensive patients engaged in skilled activity.

Correlation between doses of oxazepam and their effects on performance of a standardised test battery

It was found that the doses correlated highly with most of the psychometric variables determined, implying that the test battery is sensitive to drug effects.

Effects of alprazolam and diazepam on the daytime sleepiness of non-anxious subjects

Results suggested that tolerance to alprazolam's sedative effects may be separable from tolerance to its antianxiety effects (which develops after at least 4 weeks), and selective tolerance to this side effect is highly desirable.

Differential effects of alprazolam and buspirone upon acquisition, retention, and retrieval processes in memory.

A neuroantomical/neurophysiological model is proposed to explain the selective effects of the benzodiazepines on memory function and appears to impair acquisition and retention in dosages of 1.5 and 1.0 mg.